89315-28-6|Kemptamide|L-Serinamide, L-lysyl-L-lysyl-L-arginyl-L-prolyl-L-glutaminyl-L-arginyl-L-alanyl-L-threonyl-L-seryl-L-asparaginyl-L-valyl-L-phenylalanyl-|-范德生物科技公司

Kemptamide

NMR下载 COA and HPLC MSDS下载
names：
L-Serinamide, L-lysyl-L-lysyl-L-arginyl-L-prolyl-L-glutaminyl-L-arginyl-L-alanyl-L-threonyl-L-seryl-L-asparaginyl-L-valyl-L-phenylalanyl-
CAS号：
89315-28-6
MDL Number：
MF(分子式)： C65H112N24O18 MW(分子量)： 1517.76
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)
FMK16833-100mg	100mg	>98%	¥ 0.00	¥ 0.00		Get quote	- +	¥ 0.00

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Kemptamide
英文别名	Kemptamide;
CAS号	89315-28-6
Inchi	InChI=1S/C65H112N24O18/c1-33(2)49(61(105)84-42(29-36-15-6-5-7-16-36)57(101)85-44(31-90)51(71)95)87-58(102)43(30-48(70)94)83-59(103)45(32-91)86-62(106)50(35(4)92)88-52(96)34(3)78-54(98)39(19-12-26-76-64(72)73)80-56(100)40(22-23-47(69)93)81-60(104)46-21-14-28-89(46)63(107)41(20-13-27-77-65(74)75)82-55(99)38(18-9-11-25-67)79-53(97)37(68)17-8-10-24-66/h5-7,15-16,33-35,37-46,49-50,90-92H,8-14,17-32,66-68H2,1-4H3,(H2,69,93)(H2,70,94)(H2,71,95)(H,78,98)(H,79,97)(H,80,100)(H,81,104)(H,82,99)(H,83,103)(H,84,105)(H,85,101)(H,86,106)(H,87,102)(H,88,96)(H4,72,73,76)(H4,74,75,77)/t34-,35+,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,49-,50-/m0/s1
InchiKey	XXCSQHMDTJAWNX-PVKGJVGDSA-N
分子式 Formula	C65H112N24O18
分子量 Molecular Weight	1517.76
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Kemptamide(CAS:89315-28-6):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Kemptamide is a 13-residue synthetic peptide.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Botterell SH, Jans DA, Hemmings BA. Characterization of two mutants of the LLC-PK1 porcine kidney cell line affected in the catalytic subunit of the cAMP-dependent protein kinase. Eur J Biochem. 1987 Apr 1;164(1):39-44. PubMed PMID: 2435550.

[2]Tokumitsu H, Hatano N, Inuzuka H, Ishikawa Y, Uyeda TQ, Smith JL, Kobayashi R. Regulatory mechanism of Dictyostelium myosin light chain kinase A. J Biol Chem. 2004 Jan 2;279(1):42-50. Epub 2003 Oct 21. PubMed PMID: 14570871.

[3] Das PR, Pramanik BN. Fast atom bombardment mass spectrometric characterization of peptides. Mol Biotechnol. 1998 Apr;9(2):141-54. Review. PubMed PMID: 9658391.

[4] Foster C, Van Fleet M, Marshak A. Tryptic digestion of myosin light chain kinase produces an inactive fragment that is activated on continued digestion. Arch Biochem Biophys. 1986 Dec;251(2):616-23. PubMed PMID: 3800388.

[5] Shiraga H, Stallwood D, Ebadi M, Pfeiffer R, Landers D, Paul S. Inhibition of calmodulin-dependent myosin light-chain kinase by growth-hormone-releasing factor and vasoactive intestinal peptide. Biochem J. 1994 Jun 15;300 ( Pt 3):901-5. PubMed PMID: 8010976; PubMed Central PMCID: PMC1138250.

6: Emerick MC, Agnew WS. Identification of phosphorylation sites for adenosine 3',5'-cyclic phosphate dependent protein kinase on the voltage-sensitive sodium channel from Electrophorus electricus. Biochemistry. 1989 Oct 17;28(21):8367-80. PubMed PMID: 2557902.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开